Revolutionizing Brain Tumor Diagnosis and Management

Read More

NGS Based Tissue Biopsy

Utilising advanced sequencing technology and proprietary algorithms.

Read More

Liquid Biopsy Diagnostics

AI/ML driven diagnostics from a few drops of blood

Read More

Pioneering Brain Tumor Diagnostics

At Exsegen Genomics, we are pioneering the future of brain tumor diagnostics through innovative technologies and cutting-edge research. Our mission is to revolutionize the way brain tumors are detected and treated, providing hope and improved outcomes for patients worldwide.

Tissue Biopsy

A tissue biopsy NGS (Next Generation Sequencing) test, custom-built to encompass all brain tumors. Providing DNA methylation testing for all difficult to diagnose tumors.

Read More

Liquid Biopsy

Replacing the surgical biopsy with a sample of peripheral venous blood - bringing together a deep understanding of cancer biology and the magic of machine learning algorithms in the diagnosis, monitoring and management of brain tumor patients.

Read More

Bio Repository

One of the world’s largest brain tumor repositories, with tissue, blood, all clinical / pathological data and data on survival. This forms the backbone of all the research that is done prior to launching our tests.

Read More

Technology

Cutting edge and advanced technology solutions with the potential to revolutionise the way cancer diagnosis and research is done.

Read More

About Us

We are a brain tumor company focused on improving the accuracy of brain tumor diagnosis, reducing morbidity and improving the safety and efficacy of treatment.

Read More

Our Current Presence

We are currently present in Bengaluru, Chennai, Delhi/NCR, and Hyderabad and are collaborating with 70+ neurosurgeons in more than 20+ hospitals.

View Our Network

Partner with Exsegen

Partner with us and join our mission to revolutionize brain tumor diagnostics and management - connect with us today.

Get in Touch